Glaxosmi. Pharma

{
  "main_header": {
    "sid": 793005,
    "name": "Glaxosmi. Pharma",
    "stock_name": "Glaxosmi. Pharma",
    "full_name": "Glaxosmithkline Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/glaxosmi-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,354.80",
    "chg": -11.8,
    "chgp": "-0.5%",
    "dir": -1,
    "prev_price": "2,366.60",
    "mcapval": "40,076.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500660,
    "symbol": "GLAXO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE159A01016",
    "curr_date": "Jun 25, 03:30 PM",
    "curr_time": "08:36 AM",
    "last_traded_at": "Jun 25, 03:30 PM IST",
    "bse_nse_vol": "1.26 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 25, 2026",
    "traded_date_str": "2026 06 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/glaxosmi-pharma-793005-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/glaxosmithkline-pharmaceuticals-ltd-is-rated-sell-4073159",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/Glaxosmithkline_mojoScore_4073159.png",
        "date": "2026-06-25 10:10:05",
        "description": "Glaxosmithkline Pharmaceuticals Ltd is rated Sell by MarketsMOJO. This rating was last updated on 20 Oct 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 25 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-4068106",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/Glaxosmithkline_technicaldot_4068106.png",
        "date": "2026-06-23 08:05:20",
        "description": "Glaxosmithkline Pharmaceuticals Ltd (NSE: 793005) has experienced a notable shift in its technical momentum, moving from a bearish to a mildly bearish stance as of late June 2026. Despite a modest day gain of 1.40%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical parameter changes, contextualising them within the broader market and sector trends to provide investors with a comprehensive view of the stock’s current positioning."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/glaxosmithkline-pharmaceuticals-ltd-is-rated-sell-4052873",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/Glaxosmithkline_mojoScore_4052873.png",
        "date": "2026-06-14 10:10:04",
        "description": "Glaxosmithkline Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd Drops 1.92%: Bearish Momentum and 52-Week Lows Define Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-drops-192-bearish-momentum-and-52-week-lows-define-week-4052222",
        "imagepath": "",
        "date": "2026-06-13 17:08:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Stock hits 52-week low of Rs.2,184 amid technical downgrade</p>\n                    <p><strong>2 June:</strong> New 52-week low recorded at Rs.2,166.6</p>\n                    <p><strong>5 June:</strong> Week closes at Rs.2,166.30, down 1.92% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,208.70</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.2,166.30</div><div class=\"stat-change negative\">-1.92%</div></div>\n                    <div class=\"stat-item\"..."
      },
      {
        "title": "Markets Rally, But Glaxosmithkline Pharmaceuticals Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-falls-to-52-week-low-of-rs209595-4049027",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/Glaxosmithkline_priceRelatedfactors_4049027.png",
        "date": "2026-06-12 10:39:25",
        "description": "While the broader market showed resilience with the Sensex gaining nearly 1% on 12 Jun 2026, Glaxosmithkline Pharmaceuticals Ltd slipped to a fresh 52-week low of Rs. 2,095.95, marking a stark divergence from the general market trend."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd Falls to 52-Week Low of Rs 2119 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-falls-to-52-week-low-of-rs2119-4046674",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/Glaxosmithkline_priceRelatedfactors_4046674.png",
        "date": "2026-06-11 11:36:12",
        "description": "For the second consecutive session, Glaxosmithkline Pharmaceuticals Ltd has slipped further, hitting a fresh 52-week low of Rs 2119 on 11 Jun 2026, marking a 3.03% decline over the last two days amid broader market volatility."
      },
      {
        "title": "Markets Rally, But Glaxosmithkline Pharmaceuticals Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-falls-to-52-week-low-of-rs213605-4037670",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/Glaxosmithkline_priceRelatedfactors_4037670.png",
        "date": "2026-06-08 09:46:26",
        "description": ""
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/glaxosmithkline-pharmaceuticals-ltd-is-rated-sell-4033685",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/Glaxosmithkline_mojoScore_4033685.png",
        "date": "2026-06-03 10:10:03",
        "description": "Glaxosmithkline Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 June 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Five Consecutive Losses Push Glaxosmithkline Pharmaceuticals Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-falls-to-52-week-low-of-rs21666-4030261",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/Glaxosmithkline_priceRelatedfactors_4030261.png",
        "date": "2026-06-02 09:47:58",
        "description": "For the fifth consecutive session, Glaxosmithkline Pharmaceuticals Ltd has closed lower, slipping to a fresh 52-week low of Rs 2,166.6 on 2 Jun 2026. This decline extends the stock’s year-long underperformance, with a 33.52% drop compared to the Sensex’s 9.04% fall over the same period."
      }
    ],
    "total": 5198,
    "sid": "793005",
    "stock_news_url": "https://www.marketsmojo.com/news/glaxosmithkline-pharmaceuticals-793005"
  },
  "announcements": [
    {
      "details": "GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding 'Change of name of Registrar and Transfer Agent'.",
      "source": "NSE",
      "caption": "GlaxoSmithKline Pharmaceuticals Limited - Updates",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding 'Submission of Disclosure on Related Party Transactions '.",
      "source": "NSE",
      "caption": "GlaxoSmithKline Pharmaceuticals Limited - Updates",
      "datetime": "30-Oct-2019"
    },
    {
      "details": "GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding 'Results publication '.",
      "source": "NSE",
      "caption": "GlaxoSmithKline Pharmaceuticals Limited - Updates",
      "datetime": "23-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Glaxosmithkline Pharmaceuticals Ltd has declared <strong>570%</strong> dividend, ex-date: 29 May 26",
          "dt": "2026-05-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Glaxosmithkline Pharmaceuticals Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Sep 18",
          "dt": "2018-09-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Glaxosmithkline Pharmaceuticals Ltd is Rated Sell

2026-06-25 10:10:05

Glaxosmithkline Pharmaceuticals Ltd is rated Sell by MarketsMOJO. This rating was last updated on 20 Oct 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 25 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-23 08:05:20

Glaxosmithkline Pharmaceuticals Ltd (NSE: 793005) has experienced a notable shift in its technical momentum, moving from a bearish to a mildly bearish stance as of late June 2026. Despite a modest day gain of 1.40%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical parameter changes, contextualising them within the broader market and sector trends to provide investors with a comprehensive view of the stock’s current positioning.

Read full news article

Glaxosmithkline Pharmaceuticals Ltd is Rated Sell

2026-06-14 10:10:04

Glaxosmithkline Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Glaxosmithkline Pharmaceuticals Ltd Drops 1.92%: Bearish Momentum and 52-Week Lows Define Week

2026-06-13 17:08:58

Key Events This Week

1 June: Stock hits 52-week low of Rs.2,184 amid technical downgrade

2 June: New 52-week low recorded at Rs.2,166.6

5 June: Week closes at Rs.2,166.30, down 1.92% for the week

Week Open

Rs.2,208.70

Week Close

Rs.2,166.30

-1.92%

Read full news article

Markets Rally, But Glaxosmithkline Pharmaceuticals Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-06-12 10:39:25

While the broader market showed resilience with the Sensex gaining nearly 1% on 12 Jun 2026, Glaxosmithkline Pharmaceuticals Ltd slipped to a fresh 52-week low of Rs. 2,095.95, marking a stark divergence from the general market trend.

Read full news article

Glaxosmithkline Pharmaceuticals Ltd Falls to 52-Week Low of Rs 2119 as Sell-Off Deepens

2026-06-11 11:36:12

For the second consecutive session, Glaxosmithkline Pharmaceuticals Ltd has slipped further, hitting a fresh 52-week low of Rs 2119 on 11 Jun 2026, marking a 3.03% decline over the last two days amid broader market volatility.

Read full news article

Markets Rally, But Glaxosmithkline Pharmaceuticals Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-06-08 09:46:26

Read full news article

Glaxosmithkline Pharmaceuticals Ltd is Rated Sell

2026-06-03 10:10:03

Glaxosmithkline Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 June 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Five Consecutive Losses Push Glaxosmithkline Pharmaceuticals Ltd to a New 52-Week Low

2026-06-02 09:47:58

For the fifth consecutive session, Glaxosmithkline Pharmaceuticals Ltd has closed lower, slipping to a fresh 52-week low of Rs 2,166.6 on 2 Jun 2026. This decline extends the stock’s year-long underperformance, with a 33.52% drop compared to the Sensex’s 9.04% fall over the same period.

Read full news article

View All News